REMINDER: Registrations to apply for the 100% Fund grant in infant leukemia due Feb 1
C17 is pleased to announce a call for applications for the The 100% Fund Grant Competition targeting INFANT LEUKEMIA.
The purpose of The 100% Fund Grant Competition is to target directly pediatric cancers that are rare and hard to treat—cancers that have not responded to available therapies. Applications addressing infant leukemia will be considered for the 2019 100% Fund Grant Competition.
Projects can range from discovery to clinical trials, but must be focused towards a treatment intervention. The goal is to fund research with the potential to deliver improved treatment and increased survival rates.
Please note that this is a reissue of the call for application for research in infant leukemia. The 100% Fund LOI for infant leukemia is now replaced by a Letter of Registration (LOR) that is due by 1 Feb 2019 (4pm MT). The registration form can be downloaded from C17.ca and asks for brief administrative details, draft project title, research areas and a very brief/general project description. The 100% Fund Grants targeting infant leukemia will be reviewed in conjunction with the ongoing 2018/2019 Round 22 of grants due 13 April 2019.
The submission deadline for C17 LORs is February 01, 2019 at 4 PM MT.
- The 100% Fund Infant Leukemia Round 2B Call for Letters of Registration
- The 100% Fund Letter of Registration form for infant leukemia
- C17 Grant Application Form (grants due 13-Apr-2019 MT)
- C17 Application Instructions and Award Guide (ver 13-Nov-2018)
Application forms and the guidance document also can be downloaded from the C17 website (www.c17.ca) under Committees> Research Network.